Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
WO 2022225779
MÉTHODES ET COMPOSITIONS PERMETTANT DE FAVORISER LA CICATRISATION DE PLAIES
granted -
US 11478500
Anticancer compositions and methods for making and using them
granted -
US 11479611
HLA-G specific chimeric antigen receptor, nucleic acid, HLA-G specific chimeric antigen receptor expression plasmid, HLA-G specific chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer
granted -
US 11479551
MTA-cooperative PRMT5 inhibitors
granted -
US 11479602
Methods of treating C5-associated diseases comprising administering anti-C5 antibodies
granted -
US 11479613
Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins
granted -
US 11479617
Chelator-functionalized glycosaminoglycans
granted -
US 11479614
Methods for treating cancer or modulating T cells or NK cells in a subject with cancer by administering cells comprising chimeric cytokine receptors
granted -
US 11479545
Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction
granted -
US 11479770
Use of p38 inhibitors to reduce expression of DUX4
granted -
US 11479556
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
granted -
US 11478568
Radioactive cement
granted -
US 11479576
Nucleic acid prodrugs
granted -
US 11479560
OX2R compounds
granted -
US 11479579
Therapeutic compounds and methods
granted -
US 11479601
Antibodies specific to Sonic Hedgehog and method of use thereof
granted -
US 11479530
Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment
granted -
US 11479595
Methods for modulating an immune response
granted -
US 11479769
Technique for treating cancer using structurally-reinforced S-TuD
granted -
US 11478542
Immunogenic RSV polypeptides
granted -
US 11478425
Extended release compositions comprising pyridostigmine
granted -
US 11478541
Method for inactivating Zika virus and for determining the completeness of inactivation
granted -
US 11479543
Heterocyclic RIP1 kinase inhibitors
granted -
US 11478556
Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.